Blog

No one is saying that clinical trial sites, sponsors, and contract research organizations (CROs) can’t symbolically gather 'round the campfire and get along with one another. In fact, they can and must, if the clinical research enterprise is to keep running on all cylinders. So it is that, in the forthcoming August issue of Clinical Researcher, we consider the theme of “Better Together: Getting Sites, Sponsors, and CROs All on the Same Page” by way of a variety of contributors who address the nuances of these potentially rewarding and potentially fraught ties between research partners.

Avelino Loquere, MD, RN, CCRP, CCRC, FACRP, reflects on more than 20 years in clinical research, sharing insights on mentoring, certification, AI, participant trust, and why investing in people will be essential to the future of the profession as ACRP celebrates its 50th anniversary.

Some parts of the world get much more attention for it than others, but the professionals of the clinical research enterprise are active all over the globe, often through multinational efforts requiring careful coordination and regulatory finesse. In this blog, ACRP is pleased to have Tariro Makadzange, MD, PhD, Chief Executive Officer of the Africa Clinical Research Network, share some details on the network's mission and activities.

The value of deploying electronic informed consent (eConsent) technology is widely considered in terms of the comprehension, satisfaction, and retention of the clinical trial participants for whom consent documentation is a critical window on the complexities of trial-related processes and expectations. However, the authors of a forthcoming pair of ACRP Clinical Researcher articles whose lessons will be explored an ACRP Webinar this month say that a broader assessment of eConsent’s real-world impact is vital to ensuring that it delivers on its full promises for study sites and sponsors in addition to the participants signing the informed consent form’s bottom line.

Christina Brennan, MD, MBA, CCRC, FACRP, reflects on how her service to ACRP "has been rich with proud moments," and on why her outlook for the clinical research profession is one of "cautious optimism, tempered by a realistic understanding of the significant hurdles ahead."